IL22 and inflammatory bowel disease: Th17 cells mainly play a proinflammatory role in the pathogenesis of IBD and exacerbate the intestinal inflammatory response through the proinflammatory cytokines IL-17/IL-22 [38].We observed that upon EEN treatment, the frequency of Th17 cells decreased significantly at weeks 4 and 8.